OcuRes Consult is founded on over 15 years of PhD-level experience in biomedical sciences and preclinical research. The consultancy combines broad translational expertise with deep specialization in ophthalmology. Programs led under this expertise have successfully advanced from early discovery through preclinical development and into Phase 2 clinical trials.
OcuRes Consult supports various biotech companies, academic groups, and CRO partners in navigating (ophthalmic) preclinical drug development, regulatory submissions, and investor-facing requirements—bridging the gap between scientific innovation and successful clinical progression.
If you’re interested in collaborating or need support with your (ophthalmic) preclinical programs, please feel free to reach out.
Copyright © 2025 OcuRes Consult - All Rights Reserved.